FROM PRMA CONSULTING
Drive payer submission readiness for your Phase 2 and 3 products
Read MoreBrand Marketing / Communications
FDA set an all-time record of new drug approvals in 2018
We’ll have to wait until after the government shutdown that started on Dec. 22 for an official statement, but in the meantime FDA had posted considerable information on the volume of drug approvals granted during calendar year 2018. The primary […]
Read MoreHIV/AIDS treatment: Improving the trajectory for all stakeholders
Since its reign of terror began in the early 1980s, human immunodeficiency virus (HIV) has infected at least 76 million people worldwide. According to the World Health Organization (WHO), by the end of 2017, HIV-related disease had claimed 35 million […]
Read MoreClinical value translates into commercial success, finds Trinity Partners study
It is common-sensical to find that a new drug with true clinical value is also one that is more successful commercially, but in these days of intense pressure on drug pricing, stern formulary decisions and the looming introduction of biosimilars, […]
Read MoreActelion Pharmaceuticals settles with DoJ over patient copay improprieties
Now a subsidiary of Johnson & Johnson, Actelion had been under investigation by the Office of Inspector General, HHS, over financial assistance provided by the company for its pulmonary arterial hypertension (PAH) drugs during 2014-15. The assistance was funneled through […]
Read MoreMACRA looms large in community oncologists’ practice perspectives
A second annual “Oncology Insights” report from Cardinal Health Specialty Solutions includes a survey of some top-of-mind issues among community oncologists, who remain a vital part of how oncology is managed in the US health system. The key takeaways are: […]
Read MoreSenderra Rx expands its specialty pharmacy network
While there are hundreds of pharmacies accredited for specialty dispensing, only a small number operate both nationally and separately from the giant mail order pharmacies operated by pharmacy benefit managers. Now, Dallas-based Senderra Rx has expanded its footprint with a […]
Read MorePatient service program are loosely monitored for regulatory compliance, says Helio Health
Particularly for specialty pharmaceuticals that require lots of follow-on services, the pharma industry is investing in a growing number of patient support programs, both financial (copay programs, etc.) and advisory or educational (for both HCPs and patients). But there are […]
Read MoreAdvocacy group warns employers about the legal risks of copay accumulators
By bringing regulatory considerations from longstanding governmental rules on how employer-based health insurance is managed, a Washington advocacy group is fighting the adoption of copay accumulators. The group, the Alliance for the Adoption of Innovations in Medicine, is not itself […]
Read MoreAmerisourceBergen surveys the full range of pharmacy businesses
Tagged as the inaugural Pharmacy Check-Up: Activity & Barriers to Care Analysis, the survey compares pharmacists’ current and hoped-for future activities across the full range of pharmacy types: chain, independent, hospital and specialty. ABC is in an interesting position to […]
Read More